Wire · technology
QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 2 September 2026 · Fusion42 review
QC Ware and IonQ demonstrated a hybrid quantum-classical workflow on IonQ's Forte quantum hardware that models enzyme active sites with chemical accuracy, enabling more precise predictions of drug candidate binding energy to improve early-stage drug discovery.
This Wire brief sits within Fusion42's coverage of Quantum Computing and Drug Discovery.
◆ ◆ The Wire takeaway
Drug discovery founders can now leverage hybrid quantum workflows as IonQ's hardware proves flexible and accurate enough to enhance candidate ranking and toxicity prediction. The tech switch from classical-only to hybrid systems creates a rare chance to accelerate and improve metabolic risk assessment.
◆ Coverage
1 source · 2 Sep 2026
◆ Related on Wire
◆ Topics